DXCM - Latest News
DexCom, Inc. (DXCM), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $33.87B. Trailing twelve-month P/E ratio is 34.45. Beta to the broader market is 1.41.
The article list below shows the most recent DXCM headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent DXCM Headlines
Here's Why DexCom (DXCM) is a Strong Growth Stock
zacks.com - Aug 13, 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
zacks.com - Aug 12, 2026
DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.
Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?
zacks.com - Aug 12, 2026
DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?
zacks.com - Aug 12, 2026
DexCom's 52. 5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?
zacks.com - Aug 12, 2026
DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.
How News Affects DXCM Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track DXCM's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked DXCM news questions
- What is the latest DXCM news headline?
- The most recent DXCM headline (Aug 13, 2026) is "Here's Why DexCom (DXCM) is a Strong Growth Stock". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the DXCM news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What DXCM news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual DXCM options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.